Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

[MASK (Mobile Airways Sentinel Network), a mobile App with ARIA's comprehensive solution in Spanish-speaking countries].

Larenas-Linnemann D, Mullol J, Ivancevich JC, Anto JM, Cardona V, Dedeu T, Rodríguez-González M, Huerta-Villalobos YR, Neffen H, Fuentes-Pérez JM, Rodríguez-Zagal E, Valero A, Zernotti M, Bartra J, Alobid I, Castillo-Vizuete JA, Dordal T, Hijano R, Picado C, Sastre J, Blua AE, Jares E, Lavrut AJ, Máspero J, Bedolla-Barajas M, Burguete-Cabañas MT, Costa-Domínguez MC, Domínguez-Silva M, Espinoza-Contreras JG, Gálvez-Romero JL, García-Cobas CY, García-Cruz MLH, Hernández-Velázquez L, Luna-Pech JA, Matta JJ, Mogica-Martínez MD, Rivero-Yeverino D, Ruiz LT, Del Río-Navarro BE, Gómez-Vera J, Macías-Weinmann A, Murray R, Onorato G, Laune D, Bedbrook A, Bousquet J.

Rev Alerg Mex. 2019 Apr-Jun;66(2):263-268. doi: 10.29262/ram.v66i2.628. Spanish.

PMID:
31200425
2.

Discriminatory Molecular Biomarkers of Allergic and Nonallergic Asthma and Its Severity.

Baos S, Calzada D, Cremades-Jimeno L, de Pedro M, Sastre J, Picado C, Quiralte J, Florido F, Lahoz C, Cárdaba B.

Front Immunol. 2019 May 9;10:1051. doi: 10.3389/fimmu.2019.01051. eCollection 2019.

3.

[MASK (Mobile Airways Sentinel Network). ARIA's comprehensive solution for mobile app for the multimorbidity of allergic rhinitis and asthma].

Larenas-Linnemann D, Mullol J, Ivancevich JC, Antó JM, Cardona V, Dedeu T, Rodríguez-González M, Huerta Y, Neffen H, Fuentes-Pérez JM, Rodríguez-Zagal E, Valero A, Zernotti M, Bartra J, Alobid I, Castillo-Vizuete JA, Dordal T, Hijano R, Picado C, Sastre J, Blua AE, Jares E, Lavrut AJ, Máspero J, Bedolla-Barajas M, Burguete M, Costa MC, Domínguez-Silva M, Espinoza-Contreras JG, Gálvez-Romero JL, García-Cobas CY, García-Cruz MLH, Hernández-Velázquez L, Luna-Pech J, Matta JJ, Mogica-Martínez MD, Rivero-Yeverino D, Ruiz-Segura LT, Del Río-Navarro B, Gómez J, Macías-Weinmann A, Murray R, Onorato G, Laune D, Bedbrook A, Bousquet J.

Rev Alerg Mex. 2019 Jan-Mar;66(1):140-146. doi: 10.29262/ram.v66i1.578. Spanish.

PMID:
31013416
4.

IL-4/IFN-γ inflammatory cytokine profile induces a deficient regulation of the IL-1β/IL-1RI/EP2/COX-2 pathway in nasal mucosa.

Machado-Carvalho L, Roca-Ferrer J, Picado C.

Respir Med. 2019 Apr;150:136-140. doi: 10.1016/j.rmed.2019.03.008. Epub 2019 Mar 20.

PMID:
30961940
5.

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers.

Roca-Ferrer J, Pujols L, Pérez-González M, Alobid I, Callejas B, Vicens-Artés S, Fuentes M, Valero A, Picado C, Castor D, Nguyen D, Mullol J.

Allergy Asthma Clin Immunol. 2018 Dec 18;14:86. doi: 10.1186/s13223-018-0311-4. eCollection 2018.

6.

Asthma: A New Cardiovascular Risk Factor?

Picado C, Pernigotti A, Arismendi E.

Arch Bronconeumol. 2019 Jul;55(7):353-354. doi: 10.1016/j.arbres.2018.10.016. Epub 2018 Dec 14. English, Spanish. No abstract available.

7.

Asthma, rhinitis, and nasal polyp multimorbidities.

Castillo Vizuete JA, Sastre J, Del Cuvillo Bernal A, Picado C, Martínez Moragón E, Ignacio García JM, Cisneros Serrano C, Álvarez Gutiérrez FJ, Mullol Miret J.

Arch Bronconeumol. 2019 Mar;55(3):146-155. doi: 10.1016/j.arbres.2018.09.001. Epub 2018 Nov 16. English, Spanish.

8.

Overnight Change in Urinary Prostacyclin and Thromboxane in Obstructive Sleep Apnea.

Suarez-Giron MC, Almendros I, Roca-Ferrer J, Picado C.

Arch Bronconeumol. 2019 Jun;55(6):334-336. doi: 10.1016/j.arbres.2018.09.017. Epub 2018 Nov 5. English, Spanish. No abstract available.

9.

Nonallergic Asthma and Its Severity: Biomarkers for Its Discrimination in Peripheral Samples.

Baos S, Calzada D, Cremades-Jimeno L, Sastre J, Picado C, Quiralte J, Florido F, Lahoz C, Cárdaba B.

Front Immunol. 2018 Jun 21;9:1416. doi: 10.3389/fimmu.2018.01416. eCollection 2018.

10.

Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea.

Suarez-Giron MC, Castro-Grattoni A, Torres M, Farré R, Barbé F, Sánchez-de-la-Torre M, Gozal D, Picado C, Montserrat JM, Almendros I.

Front Physiol. 2018 May 24;9:600. doi: 10.3389/fphys.2018.00600. eCollection 2018.

11.

The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up.

Muñoz X, Álvarez-Puebla MJ, Arismendi E, Arochena L, Ausín MDP, Barranco P, Bobolea I, Cañas JA, Cardaba B, Crespo A, Del Pozo V, Domínguez-Ortega J, Fernandez-Nieto MDM, Giner J, González-Barcala FJ, Luna JA, Mullol J, Ojanguren I, Olaguibel JM, Picado C, Plaza V, Quirce S, Ramos D, Rial M, Romero-Mesones C, Salgado FJ, San-José ME, Sánchez-Diez S, Sastre B, Sastre J, Soto L, Torrejón M, Urnadoz M, Valdes L, Valero A, Cruz MJ.

Arch Bronconeumol. 2018 Mar 19. pii: S0300-2896(18)30009-7. doi: 10.1016/j.arbres.2017.12.012. [Epub ahead of print] English, Spanish.

12.

Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.

Martínez-Rivera C, Crespo A, Pinedo-Sierra C, García-Rivero JL, Pallarés-Sanmartín A, Marina-Malanda N, Pascual-Erquicia S, Padilla A, Mayoralas-Alises S, Plaza V, López-Viña A, Picado C.

Respir Med. 2018 Feb;135:22-28. doi: 10.1016/j.rmed.2017.12.013. Epub 2018 Jan 3.

PMID:
29414449
13.

Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival.

Ainsua-Enrich E, Serrano-Candelas E, Álvarez-Errico D, Picado C, Sayós J, Rivera J, Martín M.

J Immunol. 2018 Feb 1;200(3):1227. doi: 10.4049/jimmunol.1701691. Epub 2017 Dec 27. No abstract available.

14.

Duration of the efficacy of omalizumab after treatment discontinuation in 'real life' severe asthma.

Vennera MDC, Sabadell C, Picado C; Spanish Omalizumab Registry.

Thorax. 2018 Aug;73(8):782-784. doi: 10.1136/thoraxjnl-2017-210017. Epub 2017 Oct 27.

PMID:
29079610
15.

Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis.

Muñoz-Cano R, Pascal M, Araujo G, Goikoetxea MJ, Valero AL, Picado C, Bartra J.

Front Immunol. 2017 Sep 26;8:1193. doi: 10.3389/fimmu.2017.01193. eCollection 2017. Review.

16.

Role of Cyclooxygenase-2 on Intermittent Hypoxia-Induced Lung Tumor Malignancy in a Mouse Model of Sleep Apnea.

Campillo N, Torres M, Vilaseca A, Nonaka PN, Gozal D, Roca-Ferrer J, Picado C, Montserrat JM, Farré R, Navajas D, Almendros I.

Sci Rep. 2017 Mar 16;7:44693. doi: 10.1038/srep44693.

17.

Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).

Munoz-Cano R, Torrego A, Bartra J, Sanchez-Lopez J, Palomino R, Picado C, Valero A.

Eur Respir J. 2017 Mar 2;49(3). pii: 1501885. doi: 10.1183/13993003.01885-2015. Print 2017 Mar.

18.

Respiratory, ocular and skin health in recreational and competitive swimmers: Beneficial effect of a new method to reduce chlorine oxidant derivatives.

Gomà A, de Lluis R, Roca-Ferrer J, Lafuente J, Picado C.

Environ Res. 2017 Jan;152:315-321. doi: 10.1016/j.envres.2016.10.030. Epub 2016 Nov 8.

PMID:
27835856
19.

Assessing biomarkers in a real-world severe asthma study (ARIETTA).

Buhl R, Korn S, Menzies-Gow A, Aubier M, Chapman KR, Canonica GW, Picado C, Martin N, Escobar RA, Korom S, Hanania NA.

Respir Med. 2016 Jun;115:7-12. doi: 10.1016/j.rmed.2016.04.001. Epub 2016 Apr 14.

20.

Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.

Vennera Mdel C, Valero A, Uría E, Forné C, Picado C.

Clin Drug Investig. 2016 Jul;36(7):567-78. doi: 10.1007/s40261-016-0402-2.

PMID:
27142072

Supplemental Content

Loading ...
Support Center